Le Lézard
Classified in: Business
Subject: RCN

Mackenzie Investments and Canada Life Investment Management Ltd. Announce Proposed Fund Reorganizations


TORONTO, Nov. 12, 2021 /CNW/ - Mackenzie Financial Corporation ("Mackenzie Investments" or "Mackenzie") and Canada Life Investment Management Ltd. ("CLIML") today announced proposals to reorganize the funds outlined below (each, a "Reorganization") on a tax deferred basis, subject to regulatory approval and investor approval at special meetings to be held on January 11, 2022.

If approved, the Reorganizations will result in investors who hold Canada Life series units of the applicable Mackenzie mutual funds (the "Funds") to be transitioned to corresponding and substantially similar mutual funds managed by CLIML.

These Reorganizations follow a larger set of transactions which occurred on December 31, 2020 whereby Mackenzie transitioned its responsibilities as manager and trustee of the Canada Life Mutual Funds (formerly the Quadrus Group of Funds) and the Canada Life Pathways Funds to CLIML.

The proposed Reorganizations were not able to be initiated until the wind-up of Mackenzie's mutual fund corporation, Mackenzie Financial Capital Corp., which occurred on July 30, 2021.

Mackenzie Fund

Canada Life Fund

Reorganization Date

Mackenzie Global Growth Fund

Canada Life Global Growth Opportunities Fund

January 28, 2022

Mackenzie US Small-Mid Cap Growth Fund

Canada Life U.S. Small-Mid Cap Growth Fund

January 28, 2022

Mackenzie Emerging Markets Fund II

Canada Life Emerging Markets Equity Fund

January 28, 2022

Mackenzie Ivy European Fund

Canada Life European Equity Fund

March 11, 2022

Mackenzie Precious Metals Fund

Canada Life Precious Metals Fund

March 11, 2022

The proposals outlined above will have no impact on Mackenzie series investors. Investors who hold the Canada Life series will receive additional information within an information circular to be made available in December, 2021 at www.mackenzieinvestments.com and www.canadalife.com and at www.sedar.com.

About Mackenzie Investments

Mackenzie Investments is a leading investment management firm with approximately $207.4 billion in assets under management as of October 31, 2021. Mackenzie provides investment solutions and related services to more than one million retail and institutional clients through multiple distribution channels. Founded in 1967, Mackenzie is a global asset manager with offices across Canada as well as in Boston, Dublin, London, Hong Kong and Beijing. Mackenzie is a member of IGM Financial Inc. (TSX: IGM), one of Canada's premier financial services companies. For more information, visit mackenzieinvestments.com.

About Canada Life Investment Management Ltd.

CLIML is the fund management subsidiary of The Canada Life Assurance Company, a leading insurance, wealth management and benefits provider focused on improving the financial, physical and mental well-being of Canadians. For more than 170 years, individuals, families and business owners across Canada have trusted us to provide sound guidance and deliver on the promises we've made.

SOURCE Mackenzie Investments


These press releases may also interest you

at 01:00
Brinc, a global leader in corporate innovation and venture acceleration has acquired Callmi, a MENA-centric mentorship platform that offers 1:1 video consultations with top-tier expertsCallmi will scale offerings to users and also be further...

at 00:23
OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for May 17, 2024. OKX to...

16 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 16, 2024. OKX Launches Cryptopedia Season 18, Offering Users Up to...

16 mai 2024
Mr. Narongsak Jivakanun (Second from left), CEO of PTT Global Chemical Public Company Limited (GC) presided over the signing ceremony and extended his congratulations to Krungthai Bank and NatureWorks - a joint venture of GC and a leading...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Velan Inc. ("Velan" or the "Company"), a world-leading manufacturer of industrial valves, announced today its financial results for its fourth quarter and fiscal year ended February 29, 2024. All amounts are expressed in U.S. dollars unless...



News published on and distributed by: